Ani Pharmaceuticals (ANIP) Current Taxes (2013 - 2026)

Ani Pharmaceuticals has disclosed Current Taxes across 13 years of filings, most recently posting $5.3 million for Q1 2026.

• Current Taxes for Q1 2026 came in at $5.3 million, down 62.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 million (down 62.67% YoY), and the FY2025 annual result was $2.2 million, down 60.17% from the prior year.
• Current Taxes came in at $5.3 million for Q1 2026 at Ani Pharmaceuticals, up from $2.2 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $14.2 million in Q1 2025 to a low of $594000.0 in Q3 2023.
• The 4-year median for Current Taxes is $5.5 million (2024), against an average of $6.4 million.
• Across the five-year window, Current Taxes grew 24.43% in 2025 and plunged 62.67% in 2026, its largest moves.
• Ani Pharmaceuticals' Current Taxes stood at $8.2 million in 2023, then tumbled by 31.14% to $5.6 million in 2024, then tumbled by 60.17% to $2.2 million in 2025, then soared by 136.58% to $5.3 million in 2026.
• The last three Current Taxes figures came in at $5.3 million (Q1 2026), $2.2 million (Q4 2025), and $3.3 million (Q2 2025), per Business Quant data.